Skip to main content
Log in

Tiefe Venenthrombose bei junger Frau mit heterozygoter Faktor-V-Leiden-Mutation

  • Fragen aus der Praxis
  • Published:
Gefässchirurgie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Beyth RJ, Quinn LM, Landefeld CS (1998) Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 105:91–99

    Article  CAS  PubMed  Google Scholar 

  2. Eichinger S, Minar E, Bialonczyk C et al (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA 290:1071–1074

    Article  CAS  PubMed  Google Scholar 

  3. Encke A, Haas S, Sauerland S et al (2009) S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE). VASA 38(Suppl 76):1–131

    Article  Google Scholar 

  4. Kearon C, Ginsberg JS, Kovacs MJ et al (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349:631–639

    Article  CAS  PubMed  Google Scholar 

  5. Kearon C, Kahn SR, Agnelli G et al (2008) Antithrombotic therapy for venous thromboembolic disease. Chest 133:454S–545S

    Article  CAS  PubMed  Google Scholar 

  6. Levine MN, Raskob G, Beyth RJ et al (2004) Hemorrhagic complications of anticoagulant treatment. Chest 126:287S–310S

    Article  CAS  PubMed  Google Scholar 

  7. Lidegaard O, Lokkegaard E, Svendsen AL, Agger C (2009) Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 339:b2890

    Article  PubMed  Google Scholar 

  8. Lindmarker P, Schulman S, Sten-Linder M et al (1999) The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. Thromb Haemost 81:684–689

    CAS  PubMed  Google Scholar 

  9. Palareti G, Legnani C, Cosmi B et al (2003) Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 108:313–318

    Article  PubMed  Google Scholar 

  10. Ridker PM, Goldhaber SZ, Danielson E et al (2003) Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 348:1425–1434

    Article  CAS  PubMed  Google Scholar 

  11. Hylckama V van, Helmerhorst FM, Vandenbroucke JP et al (2009) The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 339:b2921

    Article  Google Scholar 

  12. Zotz RB, Sucker C, Gerhardt A (2009) Klinische Relevanz der Thrombophilie-Diagnostik. Gefaessmedizin.net 5:4–23

    Google Scholar 

  13. Zotz RB, Gerhardt A, Segendorf H, Scharf RE (2001) Significance of hereditary risk factors in patients with spontaneous recurrent thromboembolism [abstract]. Angiology 20:58–59

    Google Scholar 

  14. Zotz RB, Sucker C, Gerhardt A (2008) Thrombophilia in pregnancy venous thromboembolism, fetal loss, preeclampsia, intrauterine growth restriction. Hamostaseologie 28:455–464

    CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R.B. Zotz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zotz, R., Gerhardt, A. & Sucker, C. Tiefe Venenthrombose bei junger Frau mit heterozygoter Faktor-V-Leiden-Mutation. Gefässchirurgie 15, 340–344 (2010). https://doi.org/10.1007/s00772-010-0796-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00772-010-0796-8

Navigation